Shu-Mei Yang Selected Research

Shu-Mei Yang Research Topics

Disease

7	Carcinogenesis 02/2021 - 01/2012
5	Neoplasms (Cancer) 05/2016 - 06/2005
3	Stroke (Strokes) 08/2023 - 02/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2015
2	Lung Neoplasms (Lung Cancer) 08/2022 - 06/2015
2	Inflammation (Inflammations) 02/2021 - 12/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2016
2	Adenocarcinoma 05/2016 - 01/2016
2	Adenocarcinoma of Lung 01/2016 - 06/2005
1	Deglutition Disorders (Dysphagia) 08/2023
1	Sarcopenia 08/2023
1	Atrial Fibrillation 01/2022
1	Hemorrhage 01/2022
1	Myocardial Infarction 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Acute Coronary Syndrome 01/2022
1	Epilepsy (Aura) 10/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Infections 02/2021
1	Lung Injury 02/2021
1	Tendinopathy (Tendonitis) 01/2020
1	Tendon Injuries 01/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Amyloid Plaque 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Obesity 01/2018
1	Lymphadenopathy 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Dyspepsia (Indigestion) 01/2016
1	Elephantiasis 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Neoplasm Metastasis (Metastasis) 06/2015
1	Chronic Disease (Chronic Diseases) 02/2015
1	Sunburn 01/2012
1	Skin Neoplasms (Skin Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2012
4	ArsenicIBA 01/2018 - 01/2007
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 01/2016
3	cuminaldehydeIBA 05/2016 - 01/2016
2	2-methoxycinnamaldehydeIBA 01/2017 - 01/2016
1	AlbuminsIBA 08/2023
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 08/2023
1	Docetaxel (Taxotere)FDA Link 08/2022
1	Annexin A5IBA 08/2022
1	Nicotine FDA Link 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 08/2022
1	MicroRNAs (MicroRNA)IBA 08/2022
1	N(4)-oleylcytosine arabinosideIBA 01/2022
1	theasinensin AIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Vitamin K FDA Link 01/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 10/2021
1	LithiumIBA 10/2021
1	gastrodinIBA 10/2021
1	InflammasomesIBA 02/2021
1	Stromal Interaction Molecule 1IBA 02/2021
1	polyglutamineIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	PolydeoxyribonucleotidesIBA 01/2020
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2018
1	AdiponectinIBA 01/2018
1	Plant ExtractsIBA 01/2016
1	EnzymesIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	MethyltransferasesIBA 01/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016
1	CalciumIBA 06/2015
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	Tyrosine (L-Tyrosine)FDA Link 06/2015
1	Cytoskeletal ProteinsIBA 06/2015
1	Hypnotics and Sedatives (Sedatives)IBA 02/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2012
1	Pyrimidine DimersIBA 01/2012
1	CurcuminIBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	Moclobemide (Arima)IBA 01/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2011

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2021
1	Thrombectomy 08/2023
1	Stents 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Microbubbles 10/2021
1	Prolotherapy 01/2020
1	Extracorporeal Shockwave Therapy 01/2020
1	Conservative Treatment 01/2020
1	Ultrasonic Therapy 01/2020
1	Ligation 06/2015
1	Immunotherapy 01/2015